14373522 · Active · incorporated 4 years, 1 month ago · London
Biotech Biotech & Life Sciences Drug Discovery Series B+
Biotechnology company focused on research and development.
Rathlin Therapeutics is a private limited company registered at Companies House under number 14373522, incorporated on 23 September 2022, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 41 filings for this company, including 3 funding rounds. Its most recent round closed in July 2026, raising £5m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Jul 2026 | £5m | £0.5968 |
| Round 2 | Mar 2025 | £12m | £0.616 |
| Round 1 | Sep 2023 | £8.9m | £0.6313 |
Showing the 10 most recent of 41 filings.
See the complete cap table with every shareholder, founder tags, dilution across 9 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.